Morning Overview on MSN
Nine weeks of one drug left 59% of bowel-cancer patients with no detectable tumor
Thirty-two patients with locally advanced bowel cancer received a short course of the immunotherapy drug pembrolizumab before ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results